Could a New COVID Pill Crush Vaccine Sales?

Could a New COVID Pill Crush Vaccine Sales?

Submitted by admin on October 5, 2021 - 10:45am
Source: 
Motley Fool
News Tags: 
Merck
COVID-19
vaccines
molnupiravir
Ridgeback Biotherapeutics
Headline: 
Could a New COVID Pill Crush Vaccine Sales?
snippet: 
  • Merck plans to request emergency authorization for its investigational coronavirus pill as soon as possible.
  • This would offer a treatment option for non-hospitalized patients with mild-to-moderate illness.
  • So far, about 55% of Americans are vaccinated against COVID-19.

Do Not Allow Advertisers to Use My Personal information